Jefferies Financial Group Inc. Invests $641,000 in Myomo, Inc. $MYO

Jefferies Financial Group Inc. bought a new position in Myomo, Inc. (NYSEAMERICAN:MYO) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 704,275 shares of the company’s stock, valued at approximately $641,000. Jefferies Financial Group Inc. owned about 1.83% of Myomo at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Engineers Gate Manager LP raised its position in shares of Myomo by 62.8% during the 2nd quarter. Engineers Gate Manager LP now owns 30,097 shares of the company’s stock valued at $65,000 after buying an additional 11,614 shares in the last quarter. Bank of America Corp DE increased its stake in Myomo by 93.6% during the third quarter. Bank of America Corp DE now owns 30,412 shares of the company’s stock worth $27,000 after acquiring an additional 14,705 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in Myomo during the first quarter worth approximately $75,000. Invesco Ltd. bought a new stake in Myomo during the second quarter worth approximately $37,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Myomo during the second quarter worth approximately $38,000. 44.99% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Craig Hallum reissued a “buy” rating on shares of Myomo in a research note on Tuesday, March 10th. Four equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Myomo currently has an average rating of “Buy” and a consensus price target of $7.67.

Insiders Place Their Bets

In other Myomo news, Director Heather C. Getz bought 70,000 shares of the business’s stock in a transaction dated Thursday, March 12th. The shares were purchased at an average price of $0.73 per share, with a total value of $51,100.00. Following the completion of the purchase, the director owned 111,754 shares in the company, valued at $81,580.42. This represents a 167.65% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Joseph M. Jr. Manko bought 30,367 shares of the business’s stock in a transaction dated Friday, May 15th. The shares were acquired at an average cost of $0.89 per share, for a total transaction of $27,026.63. Following the purchase, the director owned 2,309,775 shares of the company’s stock, valued at approximately $2,055,699.75. The trade was a 1.33% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 438,203 shares of company stock valued at $358,416 over the last ninety days. 12.14% of the stock is owned by insiders.

Myomo Stock Performance

Shares of NYSEAMERICAN MYO opened at $1.09 on Friday. The business’s 50 day moving average is $0.81 and its two-hundred day moving average is $0.85. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.73 and a quick ratio of 2.36. Myomo, Inc. has a 1-year low of $0.61 and a 1-year high of $3.14. The stock has a market capitalization of $42.12 million, a P/E ratio of -3.03 and a beta of 1.39.

Myomo Company Profile

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.